These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8993241)
41. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
42. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
43. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass. Augoustides JG J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754 [No Abstract] [Full Text] [Related]
44. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046 [TBL] [Abstract][Full Text] [Related]
45. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ray MJ; Hawson GA; Just SJ; McLachlan G; O'Brien M Ann Thorac Surg; 1994 Apr; 57(4):981-6. PubMed ID: 8166553 [TBL] [Abstract][Full Text] [Related]
46. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of a high-dose aprotinin regimen for reducing transfusion requirements and inflammatory responses in adult cardiac surgery. Jeong DS; Kim KH; Kim CY; Kim JS J Int Med Res; 2008; 36(5):1039-48. PubMed ID: 18831899 [TBL] [Abstract][Full Text] [Related]
48. Aprotinin to decrease bleeding and intraoperative blood transfusion requirements during descending thoracic and thoracoabdominal aortic aneurysmectomy using cardiopulmonary bypass. Godet G; Bertrand M; Samama CM; Barré E; Fléron MH; Baron JF; Coriat P; Kieffer E; Viars P Ann Vasc Surg; 1994 Sep; 8(5):452-6. PubMed ID: 7529038 [TBL] [Abstract][Full Text] [Related]
49. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
50. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Rocha E; Hidalgo F; Llorens R; Melero JM; Arroyo JL; Páramo JA Circulation; 1994 Aug; 90(2):921-7. PubMed ID: 7519132 [TBL] [Abstract][Full Text] [Related]
51. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462 [TBL] [Abstract][Full Text] [Related]